EMR-L has the potential to replace ESD in resecting gastric stromal tumors smaller than 1.0 cm in diameter: A pilot study
EMR-L and ESD can achieve the same safety and complete resection rate, but the former has the advantages of simple operation, short operation duration and low hospital cost. EMR-L may serve as a new option for the treatment of GSTs.
Authors
- Peipei Luo (ORCID: https://orcid.org/0000-0002-8965-1998)
- Yi Cai (ORCID: https://orcid.org/0000-0002-7587-8956)
- Jing Cai (ORCID: https://orcid.org/0000-0002-6455-9992)
- Lixia Zhang (ORCID: https://orcid.org/0000-0002-9463-6039)
- Wenwen Xu (ORCID: https://orcid.org/0000-0001-7588-5016)
- Min Xu (ORCID: https://orcid.org/0000-0003-3930-8718)
- Yungang Liu (ORCID: https://orcid.org/0000-0002-2636-6479)
- Lijuan Xu (ORCID: https://orcid.org/0000-0002-4963-4069)
- Mingjie He (ORCID: https://orcid.org/0000-0001-5807-1870)
Institutions
- Jiangsu University (CN)
- Jintan People's Hospital (CN)
- Changzhou No.2 People's Hospital (CN)
Publication Details
- Journal
- Medicine
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1097/md.0000000000045292
- Primary Topic
- Gastrointestinal Tumor Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00